Retapamulin: what is the role of this topical antimicrobial in the treatment of bacterial infections in atopic dermatitis?

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Skin therapy letter

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 20066388
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retapamulin

  2012cited by this paper
• Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity

  2010cited by this paper
• Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity

  2009cited by this paper
• Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families

  2009cited by this paper
• Analysis of the mechanism for the development of allergic skin inflammation and the application for its treatment:keratinocytes in atopic dermatitis - their pathogenic involvement.

  2009cited by this paper
• Allergic Contact Dermatitis from Retapamulin Ointment

  2009cited by this paper
• Microbiological profile of a new topical antibacterial: retapamulin ointment 1%

  2009cited by this paper
• New insights into the mechanism and management of allergic diseases: atopic dermatitis

  2009cited by this paper
• Future perspectives in the treatment of atopic dermatitis

  2009influential reference
• In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin.

  2008cited by this paper
• Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double‐blind multicentre placebo‐controlled trial

  2008cited by this paper
• Retapamulin: a review of its use in the management of impetigo and other uncomplicated superficial skin infections.

  2008influential reference
• UV damage and DNA repair in malignant melanoma and nonmelanoma skin cancer.

  2008cited by this paper
• Spotlight on Retapamulin in Impetigo and Other Uncomplicated Superficial Skin Infections†

  2008cited by this paper
• The Melanocortin 1 Receptor and the UV Response of Human Melanocytes—A Shift in Paradigm †

  2008cited by this paper
• Susceptibility testing and resistance phenotype detection in Staphylococcus aureus strains isolated from patients with atopic dermatitis, with apparent and recurrent skin colonization

  2008cited by this paper
• Interventions to reduce Staphylococcus aureus in the management of atopic eczema.

  2008cited by this paper
• Role of Bacterial Pathogens in Atopic Dermatitis

  2007influential reference
• Stepwise Exposure of Staphylococcus aureus to Pleuromutilins Is Associated with Stepwise Acquisition of Mutations in rplC and Minimally Affects Susceptibility to Retapamulin

  2007cited by this paper
• In vitro activity against anaerobes of retapamulin, a new topical antibiotic for treatment of skin infections.

  2007cited by this paper
• Topical Retapamulin Ointment, 1%, versus Sodium Fusidate Ointment, 2%, for Impetigo: A Randomized, Observer-Blinded, Noninferiority Study

  2007cited by this paper
• Retapamulin Inhibition of Translation and 50S Ribosomal Subunit Formation in Staphylococcus aureus Cells

  2007cited by this paper
• Skin Colonization by Staphylococcus aureus in Patients With Eczema and Atopic Dermatitis and Relevant Combined Topical Therapy: A Double-Blind Multicentre Randomized Controlled Trial

  2007influential reference
• Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity

  2007cited by this paper
• Melanin content and MC1R function independently affect UVR-induced DNA damage in cultured human melanocytes.

  2006cited by this paper
• Single- and Multistep Resistance Selection Studies on the Activity of Retapamulin Compared to Other Agents against Staphylococcus aureus and Streptococcus pyogenes

  2006cited by this paper
• Activity of Retapamulin against Streptococcus pyogenes and Staphylococcus aureus Evaluated by Agar Dilution, Microdilution, E-Test, and Disk Diffusion Methodologies

  2006cited by this paper
• Biochemical Characterization of the Interactions of the Novel Pleuromutilin Derivative Retapamulin with Bacterial Ribosomes

  2006cited by this paper
• Dissecting the role of infections in atopic dermatitis.

  2006influential reference
• Cutaneous photoprotection and melanoma susceptibility: reaching beyond melanin content to the frontiers of DNA repair.

  2006cited by this paper
• Retapamulin ointment twice daily for 5 days vs oral cephalexin twice daily for 10 days for empiric treatment of secondarily infected traumatic lesions of the skin.

  2006cited by this paper
• Activity of Retapamulin (SB-275833), a Novel Pleuromutilin, against Selected Resistant Gram-Positive Cocci

  2006cited by this paper
• Topical retapamulin ointment (1%, wt/wt) twice daily for 5 days versus oral cephalexin twice daily for 10 days in the treatment of secondarily infected dermatitis: results of a randomized controlled trial.

  2006cited by this paper
• Selection of Retapamulin, a Novel Pleuromutilin for Topical Use

  2006cited by this paper
• MC1R and the response of melanocytes to ultraviolet radiation.

  2005cited by this paper
• Melanocortin-1 receptor structure and functional regulation.

  2005cited by this paper
• Staphylococcus aureus re‐colonization in atopic dermatitis: beyond the skin

  2005cited by this paper
• Skin colour and skin cancer - MC1R, the genetic link.

  2002cited by this paper
• UV damage, DNA repair and skin carcinogenesis.

  2002cited by this paper
• Human melanocortin 1 receptor variants, receptor function and melanocyte response to UV radiation.

  2002cited by this paper
• Clinical and Laboratory Investigations Staphylococcus aureus: colonizing features and influence of an antibacterial treatment in adults with atopic dermatitis

  2002influential reference
• Cancer Research UK

  2002cited by this paper
• Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus.

  2002cited by this paper
• Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color.

  2001cited by this paper
• [Melanoma: role of ultraviolet radiation: from physiology to pathology].

  2001cited by this paper
• Melanocortin-1 receptor genotype is a risk factor for basal and squamous cell carcinoma.

  2001cited by this paper
• Melanocortin-1 receptor gene variants determine the risk of nonmelanoma skin cancer independently of fair skin and red hair.

  2001cited by this paper
• Melanocortin-1-receptor gene and sun sensitivity in individuals without red hair.

  2000cited by this paper
• Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype?

  2000cited by this paper
• Flucloxacillin in the treatment of atopic dermatitis

  1998cited by this paper
• Cutaneous Oncology: Pathophysiology, Diagnosis, and Management

  1998cited by this paper
• Characterization of melanocyte stimulating hormone receptor variant alleles in twins with red hair.

  1997cited by this paper
• Variants of the melanocyte–stimulating hormone receptor gene are associated with red hair and fair skin in humans

  1995cited by this paper
• Role of bacterial flora in the pathogenesis & management of atopic dermatitis.

  1992cited by this paper
• Staphylococcus aureus skin colonization in atopic dermatitis patients.

  1985cited by this paper
• Fusidic acid plus betamethasone in infected or potentially infected eczema.

  1985cited by this paper
• The case for steroid—antibiotic combinations

  1977cited by this paper
• Co‐operative double‐blind trial of an antibiotic/ corticoid combination in impetiginized atopic dermatitis

  1976cited by this paper

• Synthesis of retapamulin from plueromutilin enhancing the purity and yield via altered halogenations process.

  2024cites this paper
• Protective Action of Cannabidiol on Tiamulin Toxicity in Humans—In Vitro Study

  2024cites this paper
• Design, synthesis and antibacterial evaluation of pleuromutilin derivatives.

  2022cites this paper
• Design of Experiment Centered Multivariate Optimization Strategy for RP-HPLC Method to Quantitate Retapamulin in Topical Cream and Microemulsion

  2020influential citation
• Design, synthesis, and biological activity evaluation of a series of pleuromutilin derivatives with novel C14 side chains.

  2020cites this paper
• Design, development and optimization of new high performance thin‐layer chromatography method for quantitation of Retapamulin in pharmaceutical formulation: Application of design of experiment

  2020cites this paper
• The PlyB Endolysin of Bacteriophage vB_BanS_Bcp1 Exhibits Broad-Spectrum Bactericidal Activity against Bacillus cereus Sensu Lato Isolates

  2019cites this paper
• Client-Centered Nursing Care 1

  2018cites this paper
• Determination of a New Pleuromutilin Derivative in Broiler Chicken Plasma by RP-HPLC-UV and Its Application to a Pharmacokinetic Study.

  2018cites this paper
• Current and Emerging Topical Antibacterials and Antiseptics: Agents, Action, and Resistance Patterns

  2017cites this paper
• Synthesis and antibacterial activities of novel pleuromutilin derivatives with a substituted pyrimidine moiety.

  2017cites this paper
• Synthesis and Pharmacological Evaluation of Novel Pleuromutilin Derivatives with Substituted Benzimidazole Moieties

  2016cites this paper
• Crystal structure of 14-((1-(benzyloxycarbonyl-amino)-2-methylpropan-2-yl)sulfanyl)acetate Mutilin, C34H49NO6S

  2016cites this paper
• In Vivo Efficacy and Toxicity Studies of a Novel Antibacterial Agent: 14-O-[(2-Amino-1,3,4-thiadiazol-5-yl)Thioacetyl] Mutilin

  2015cites this paper
• Enterobacteris en productes vegetals frescos: resistències als antibiòtics

  2015cites this paper
• Synthesis and evaluation of novel pleuromutilin derivatives with a substituted pyrimidine moiety.

  2015cites this paper
• Synthesis and biological activities of novel pleuromutilin derivatives with a substituted thiadiazole moiety as potent drug-resistant bacteria inhibitors.

  2014cites this paper
• NOVEL ANTIMICROBIAL AGENTS: A REVIEW

  2014cites this paper
• A validated stability-indicating liquid chromatographic method for the determination of retapamulin in topical dosage form.

  2014cites this paper
• Synthesis and Biological Evaluation of New Pleuromutilin Derivatives as Antibacterial Agents

  2014cites this paper
• In Vitro Activity of Retapamulin against Staphylococcus aureus Resistant to Various Antimicrobial Agents

  2013cites this paper
• Chemical Synthesis and Biological Activities of Novel Pleuromutilin Derivatives with Substituted Amino Moiety

  2013cites this paper
• Bacterial skin colonization and infections in patients with atopic dermatitis.

  2012cites this paper
• Newer Antibacterials in Therapy and Clinical Trials

  2012cites this paper
• Activity of short lipopeptides and conventional antimicrobials against planktonic cells and biofilms formed by clinical strains of Staphylococcus aureus.

  2012cites this paper
• In Vitro Activities of Retapamulin and 16 Other Antimicrobial Agents against Recently Obtained Streptococcus pyogenes Isolates

  2011cites this paper
• Contact dermatitis from topical antibiotics.

  2011cites this paper
• Unerwünschte Gäste auf und in der Haut

  2011cites this paper
• Retapamulin: focus on its use in the treatment of uncomplicated superficial skin infections and impetigo

  2010cites this paper